Zhang Fengjiao, Xie Ruiye, Munoz Frances M, Lau Serrine S, Monks Terrence J
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona Health Sciences Center, Tucson, Arizona 85721.
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona Health Sciences Center, Tucson, Arizona 85721 Department of Pediatrics and Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla,CA 92093-0651.
Toxicol Sci. 2014 Jul;140(1):118-34. doi: 10.1093/toxsci/kfu073. Epub 2014 Apr 20.
The generation of reactive oxygen species (ROS) has been implicated in the pathogenesis of renal ischemia/reperfusion injury, and many other pathological conditions. DNA strand breaks caused by ROS lead to the activation of poly(ADP-ribose)polymerase-1 (PARP-1), the excessive activation of which can result in cell death. We have utilized a model in which 2,3,5-tris(glutathion-S-yl)hydroquinone (TGHQ), a nephrotoxic and nephrocarcinogenic metabolite of hydroquinone, causes ROS-dependent cell death in human renal proximal tubule epithelial cells (HK-2), to further elucidate the role of PARP-1 in ROS-dependent cell death. TGHQ-induced ROS generation, DNA strand breaks, hyperactivation of PARP-1, rapid depletion of nicotinamide adenine dinucleotide (NAD), elevations in intracellular Ca(2+) concentrations, and subsequent nonapoptotic cell death in both a PARP- and Ca(2+)-dependent manner. Thus, inhibition of PARP-1 with PJ34 completely blocked TGHQ-mediated accumulation of poly(ADP-ribose) polymers and NAD consumption, and delayed HK-2 cell death. In contrast, chelation of intracellular Ca(2+) with BAPTA completely abrogated TGHQ-induced cell death. Ca(2+) chelation also attenuated PARP-1 hyperactivation. Conversely, inhibition of PARP-1 modulated TGHQ-mediated changes in Ca(2+) homeostasis. Interestingly, PARP-1 hyperactivation was not accompanied by the translocation of apoptosis-inducing factor (AIF) from mitochondria to the nucleus, a process usually associated with PARP-dependent cell death. Thus, pathways coupling PARP-1 hyperactivation to cell death are likely to be context-dependent, and therapeutic strategies designed to target PARP-1 need to recognize such variability. Our studies provide new insights into PARP-1-mediated nonapoptotic cell death, during which PARP-1 hyperactivation and elevations in intracellular Ca(2+) are reciprocally coupled to amplify ROS-induced nonapoptotic cell death.
活性氧(ROS)的产生与肾缺血/再灌注损伤以及许多其他病理状况的发病机制有关。由ROS引起的DNA链断裂会导致聚(ADP - 核糖)聚合酶 - 1(PARP - 1)的激活,其过度激活会导致细胞死亡。我们利用了一种模型,其中对苯二酚的肾毒性和肾致癌代谢物2,3,5 - 三(谷胱甘肽 - S - 基)对苯二酚(TGHQ)在人肾近端小管上皮细胞(HK - 2)中引起ROS依赖性细胞死亡,以进一步阐明PARP - 1在ROS依赖性细胞死亡中的作用。TGHQ诱导ROS生成、DNA链断裂、PARP - 1过度激活、烟酰胺腺嘌呤二核苷酸(NAD)快速消耗、细胞内Ca(2+)浓度升高,并随后以PARP和Ca(2+)依赖性方式导致非凋亡性细胞死亡。因此,用PJ34抑制PARP - 1完全阻断了TGHQ介导的聚(ADP - 核糖)聚合物的积累和NAD消耗,并延迟了HK - 2细胞死亡。相反,用BAPTA螯合细胞内Ca(2+)完全消除了TGHQ诱导的细胞死亡。Ca(2+)螯合也减弱了PARP - 1的过度激活。相反,抑制PARP - 1调节了TGHQ介导的Ca(2+)稳态变化。有趣的是,PARP - 1过度激活并未伴随着凋亡诱导因子(AIF)从线粒体向细胞核的转位,这一过程通常与PARP依赖性细胞死亡相关。因此,将PARP - 1过度激活与细胞死亡联系起来的途径可能取决于具体情况,旨在靶向PARP - 1的治疗策略需要认识到这种变异性。我们的研究为PARP - 1介导的非凋亡性细胞死亡提供了新的见解,在此过程中,PARP - 1过度激活和细胞内Ca(2+)浓度升高相互耦合,以放大ROS诱导的非凋亡性细胞死亡。